Thank you for your message. Currently, my therapy has not yet entered an FDA IND clinical trial process in the U.S., mainly due to funding constraints. However, I am actively working on a state-level legislative approach to gain approval for the therapy under Right-to-Try frameworks, starting with states like Florida.
I am now collaborating with U.S. doctors to launch a 100-patient clinical research study (not a formal clinical trial) aimed at supporting these legislative efforts.
If your friends are interested, please visit cdsxcancer.com and sign up as supporters of our state legislative initiative. Florida is one of the most promising states for this path, and their support could make a real difference.
Is there a place for non-cancer advocates to sign up as supporters of your Florida State Legislative approach? I am very active in my local political groups and often send emails to our legislators as an action item.
We warmly welcome non-cancer advocates who wish to support our Florida state legislative initiative. Your political experience and willingness to take action are deeply appreciated and can have a real impact.
You can visit cdsxcancer.com and submit your information through the “Support State Legislation” section. If there’s no dedicated form visible to non-patients yet, feel free to message me directly with your name, zip code, and email — I’ll make sure you’re added to our advocacy network.
Your support may help thousands of patients access this therapy under state-level Right-to-Try policies. Thank you again for standing with us.
Does it have an abscopal effect or are cancer antigens too oxidized? Would priming with immunomodulatory drugs increase the possibility of an abscopal effect like in radiation therapy?
Theoretically, yes, especially as observed in my preclinical research. However, it functions more like a direct ablation, and the distal effects are both too slow and too weak.
Our technique does not differentiate between cancer stem cells and other tumor cells during administration. However, if cancer stem cells are present within the tumor mass—where the chlorine dioxide is directly injected—they are likely to be exposed to the same high local concentrations. Given ClO₂’s broad oxidative mechanism that disrupts proteins, membranes, and nucleic acids, it’s reasonable to assume that cancer stem cells in direct contact would be similarly affected and destroyed. This is consistent with the rapid tumor necrosis we observe clinically after treatment.
Of course, further research is needed to specifically confirm its effect on CSCs. But in practice, if the entire tumor (including its microenvironment) is eliminated, the probability of residual cancer stem cells surviving in that zone is low.
I have friends dealing with cancer. One with Prostate and the other with breast cancer. Do you have clinical trials anywhere in the Florida area?
Thank you for your message. Currently, my therapy has not yet entered an FDA IND clinical trial process in the U.S., mainly due to funding constraints. However, I am actively working on a state-level legislative approach to gain approval for the therapy under Right-to-Try frameworks, starting with states like Florida.
I am now collaborating with U.S. doctors to launch a 100-patient clinical research study (not a formal clinical trial) aimed at supporting these legislative efforts.
If your friends are interested, please visit cdsxcancer.com and sign up as supporters of our state legislative initiative. Florida is one of the most promising states for this path, and their support could make a real difference.
Is there a place for non-cancer advocates to sign up as supporters of your Florida State Legislative approach? I am very active in my local political groups and often send emails to our legislators as an action item.
Thank you so much, Judy — yes, absolutely!
We warmly welcome non-cancer advocates who wish to support our Florida state legislative initiative. Your political experience and willingness to take action are deeply appreciated and can have a real impact.
You can visit cdsxcancer.com and submit your information through the “Support State Legislation” section. If there’s no dedicated form visible to non-patients yet, feel free to message me directly with your name, zip code, and email — I’ll make sure you’re added to our advocacy network.
Your support may help thousands of patients access this therapy under state-level Right-to-Try policies. Thank you again for standing with us.
Does it have an abscopal effect or are cancer antigens too oxidized? Would priming with immunomodulatory drugs increase the possibility of an abscopal effect like in radiation therapy?
Theoretically, yes, especially as observed in my preclinical research. However, it functions more like a direct ablation, and the distal effects are both too slow and too weak.
Most Western And traditional Doctors R Not going to do this ,.especially under Medicaid insurance ! They r not taught the right way at all!
Thank you for posting this, Dr. Liu.
How does this technique deal with cancer stem cells?
Our technique does not differentiate between cancer stem cells and other tumor cells during administration. However, if cancer stem cells are present within the tumor mass—where the chlorine dioxide is directly injected—they are likely to be exposed to the same high local concentrations. Given ClO₂’s broad oxidative mechanism that disrupts proteins, membranes, and nucleic acids, it’s reasonable to assume that cancer stem cells in direct contact would be similarly affected and destroyed. This is consistent with the rapid tumor necrosis we observe clinically after treatment.
Of course, further research is needed to specifically confirm its effect on CSCs. But in practice, if the entire tumor (including its microenvironment) is eliminated, the probability of residual cancer stem cells surviving in that zone is low.